STOCKHOLDERS DEFICIT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 04, 2017
Common Stock, Par Value	$ 0.00001		$ 0.00001
Common Stock, Authorized Shares	800,000,000		800,000,000
Common Stock, Issued Shares	75,056,123		75,056,123
Common Stock, Outstanding Shares	75,056,123		75,056,123
Preferred Stock, Par Value	$ 0.00001		$ 0.00001
Preferred Stock, Authorized Shares	25,000,000		25,000,000
Stock-based Compensation	$ 0	$ 0
Common stock payable	$ 16,800		$ 16,800
Unrelated Party [Member]
Common Stock, Issued Shares	960
Quaterly intallment share	120
Common stock payable	$ 16,800		$ 16,800
Number of quarterly installments	8
2017 Non-Qualified Stock Option Plan [Member]
Common Stock, Outstanding Shares	7,762,821		7,762,821
Outstanding options expiration description	The outstanding options expire on various dates beginning in 2027 through 2029
Weighted average remaining contractual life	5 years 4 months 24 days
Option Granted To Purchase Common Shares				10,000,000
Series C Preferred Stock [Member]
Preferred Stock, Authorized Shares	4,500,000		4,500,000
Preferred Stock, Issued Shares	4,355,000		4,355,000
Preferred Stock, Outstanding Shares	4,355,000		4,355,000
Description Of Voting Rights	(i) dividend rights equal to the Company’s common stock; (ii) no liquidation preference over the Company’s common stock; (iii) each share is convertible into 50 shares of the Company’s common stock; (iv) no redemption rights; (v) no call rights by the Company; and (vi) each shares votes on an “as converted” basis, such that each share currently has 50 votes on all matters brought before the Company’s common stockholders for a vote
Series B Preferred Stock [Member]
Preferred Stock, Authorized Shares	2,700,000		2,700,000
Preferred Stock, Issued Shares	2,480,482		2,480,482
Preferred Stock, Outstanding Shares	2,480,482		2,480,482
Preferred Stock Voting Rights Description	(i) dividend rights equal to the Company’s common stock; (ii) no liquidation preference over the Company’s common stock; (iii) each share is convertible into 50 shares of the Company’s common stock; (iv) no redemption rights; (v) no call rights by the Company; and (vi) no voting rights. The holders of the Series B preferred stock cannot convert their shares of Series B preferred stock if such conversion would cause the holder to beneficially own more than 4.99% of our then-outstanding common stock
Description Of Voting Rights	(i) dividend rights equal to the Company’s common stock; (ii) no liquidation preference over the Company’s common stock; (iii) each share is convertible into 50 shares of the Company’s common stock; (iv) no redemption rights; (v) no call rights by the Company; and (vi) no voting rights. The holders of the Series B preferred stock cannot convert their shares of Series B preferred stock if such conversion would cause the holder to beneficially own more than 4.99% of the Company’s then-outstanding common stock
Common Stock [Member]
Common Stock, Par Value	$ 0.00001		$ 0.00001
Common Stock, Authorized Shares	800,000,000		800,000,000
Common Stock, Issued Shares	75,056,123		75,056,123
Common Stock, Outstanding Shares	75,056,123		75,056,123
Preferred Stock, Par Value	$ 0.00001		$ 0.00001
Preferred Stock, Authorized Shares	25,000,000		25,000,000
Stock-based Compensation	$ 0	$ 0